StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > ARISTOTLE is better than GRAIL to detect early cancers

<< Previous

Bullboard Posts

Next >>

Comment by Teddy3on Sep 14, 2021 10:12pm

117 Views

Post# 33859880

RE:RE:RE:ARISTOTLE is better than GRAIL to detect early cancers

Yea, SZLS has the best most accurate revolutionary cancer test because Tripp said so...LOLOOL! You can't be serious....can you? Why is volume at zero if so? Where is all the published data to proove so? Why wouldn't a larger company swoop in and buy SZLS for peanuts compared to the potential return if so? THEY HAVE NOTHING OF VALUE, ARE YOU PEOPLE CRAZY OR ALL JUST EMPLOYEES? Every possible indicator points towards nothing of value they hold. Look at the share price! SZLS has done NOTHING to show Aristotle's value.

User image